Urology Medical Lasers Market Report 2025

The urology medical lasers market size has grown steadily in recent years. It will grow from $1.03 billion in 2024 to $1.07 billion in 2025 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to rapid technological advances, increased healthcare expenditure, rapid growth in elderly population, public health insurance reforms and strong economic growth in emerging markets.

The urology medical lasers market size is expected to see strong growth in the next few years. It will grow to $1.36 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to an increase in mergers and acquisitions, an increase in R&D and innovations, and government initiatives will drive the growth. Major trends in the forecast period include emergence of novel technologies, use of big data and artificial intelligence, innovative laser treatments for benign prostatic hyperplasia, and use of fiber-optics in laser technology.

The increasing prevalence of urological disorders is a significant factor driving the demand for the urology medical lasers market. A rise in urological cases, including conditions such as bladder cancer and prostate diseases, is fostering the need for minimally invasive surgeries and associated devices. According to statistics from the American Institute for Cancer Research, bladder cancer ranks as the sixth most common cancer in men and the 17th most common cancer in women. This upsurge in urological diseases and conditions is fueling the demand for urological surgeries, thereby supporting the growth of the urology medical lasers market.

The continued growth in the incidence of urologic conditions is anticipated to propel the urology medical lasers market further. Urologic conditions encompass a range of issues affecting the reproductive or urinary tract systems in both males and females. Common urologic diseases include kidney stones, urinary tract infections, bladder control problems, and prostate issues. Urologists utilize laser instruments in the field of urology to diagnose and treat these conditions through various procedures. For instance, the American Cancer Society's Cancer Facts and Figures 2023 report reveals approximately 82,290 new cases of bladder cancer and 16,710 deaths from bladder cancer in the United States in 2023. Additionally, in 2021, the Centers for Disease Control and Prevention reported around 24,710 catheter-associated urinary tract infections in the U.S. The rising incidence of urologic conditions is a key driver for the urology medical lasers market.

Product innovation is a key trend gaining popularity in the urology medical lasers market. The product innovations assist urologists in achieving better outcomes and deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. For instance, in November 2022, Apollo, an India-based hospital launched first Moses 2.0, an advanced laser technology to treat large kidney stones and prostate enlargement on high-risk patients in a bloodless and painless manner. Procedures conducted with Moses 2 are endoscopic and do not involve cutting open of the skin. Any size of kidney stones and the prostate can be completely treated.

Leading companies in the urology medical lasers market are focusing on developing advanced technological products, such as thulium fiber laser (TFL) systems, to deliver superior precision, minimize tissue damage, enhance stone fragmentation efficiency, and improve safety. The thulium fiber laser (TFL) system represents a high-precision medical laser technology primarily employed in urology for minimally invasive procedures, including kidney stone fragmentation and prostate tissue removal, offering greater safety and efficiency compared to traditional laser systems. For example, in February 2023, Rhein Laser Technologies Ltd., a China-based manufacturer of urology lasers, launched the UroFiber 150Q. This 150W SuperPulsed thulium fiber laser (TFL) system features innovative all-fiber technology specifically designed for optimal stone lithotripsy and BPH enucleation. It employs a customized high-brightness narrow spectrum fiber-coupling 792nm diode laser to pump the thulium fiber, producing a powerful 1940nm CW&QCW laser. In SuperPulsed mode (QCW), it can achieve a peak power of 600W, with an average output of 150W and a maximum laser repetition rate of 5000Hz at a minimum pulse energy of 0.025J. Furthermore, it can reach up to 6J pulse energy at 25Hz in pulsed mode and maintain 150W in continuous mode (CW), operating efficiently 24/7 with noise levels below 60dB, fully compliant with industry standards.

In February 2024, OmniGuide Holdings (OGH), a US-based medical device company, entered into a partnership with UROTECH to enhance UROTECH's urology technology portfolio. This collaboration will work closely with urologists to establish a global network centered around RevoLix™ HTL (Hybrid Thulium Laser Therapy), focusing specifically on advancing treatments for kidney stones and benign prostatic hyperplasia (BPH). UROTECH is a Germany-based medical technology company specializing in urology.

Major companies operating in the urology medical lasers market include Olympus Corporation, Boston Scientific Corporation, Lumenis Ltd., Richard Wolf GmbH, Quanta System S.p.A., Stryker Corporation, OmniGuide Holdings Inc., Convergent Laser Technologies, Biolitec AG, Allengers Medical Systems Limited, Changzhou Meditech Trading Co. Ltd, Shuzhou Sunan Zimmered Medical Instrument Co. LTD, Narang Medical Limited, Atlas Surgical, Auxein Medical, Seikagaku Corporation, Anatomics, SignatureOrtho, Fresenius Medical Care AG & Co, KARL STORZ, EndoMed Systems GmbH, Dornier MedTech, Braun Melsungen AG, Lisa Laser, IRE-Polus, IPG Photonics Co, Capital Clinic Riga, Nick Mertziotis MDPh.D, Moscow Next Generation Clinic, Private Gürlife Hospital, Warsaw Surgery Clinic, Laser Med Medical Centre, Clinica Tambre, Stereotactic Radiosurgery Center ‘SIGULDA’, Cook Medical Incorporated, CR Bard, Healthtronics Inc, Surgical Lasers Inc, Medtronic, Aerolase, cutera, Cynosure inc, Sciton inc, Sharplight Technologies, Syneron Medical inc, SoltaMedical inc, Alma Lasers, Euracare.

North America was the largest region in the urology medical lasers market in 2024. Asia-Pacific was the second largest region in the urology medical lasers report. The regions covered in the urology medical lasers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the urology medical lasers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

Urology medical lasers are specialized instruments utilized in urology to conduct a range of minimally invasive surgeries and treatments targeting the urinary tract, bladder, kidneys, prostate, and other related organs. These lasers function by emitting concentrated beams of light energy to accurately cut, vaporize, or fragment tissue. The benefits of using these lasers include reduced bleeding, quicker recovery times, and minimal harm to surrounding tissues.

The urology medical lasers market encompasses various types, with notable examples being the holmium laser system, diode laser system, thulium laser system, and others. Holmium laser systems are specifically employed for the removal of stones in the bladder, kidneys, ureters, or urethra through laser-based procedures. The applications of these lasers extend to treating conditions such as benign prostatic hyperplasia (BPH), urolithiasis, non-muscle-invasive bladder cancer (NMIBC), and others. The primary end-users of urology medical lasers include hospitals, clinics, and other healthcare facilities.

The urology medical lasers market research report is one of a series of new reports that provides urology medical lasers market statistics, including urology medical lasers industry global market size, regional shares, competitors with a urology medical lasers market share, detailed urology medical lasers market segments, market trends and opportunities, and any further data you may need to thrive in the urology medical lasers industry. This urology medical lasers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The urology medical lasers market consists of sales of holmium laser system, diode laser system, thulium laser system, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.